Skip to search formSkip to main contentSkip to account menu

LY 518674

Known as: LY-518674, LY518674 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PropionatesTriazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Potent and Selective PPAR-α Agonist LY518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic Syndrome
Objective—The study of PPAR-α activation on apoA-I production in humans has been limited to fibrates, relatively weak PPAR… 
2009
2009
Gateways to clinical trials.
ABT-869, Acadesine, Acetylsalicylic acid/omeprazole, Adefovir, Adefovir dipivoxil, AEG-35156, Agatolimod sodium, Albiglutide… 
2008
2008
Potent and Selective PPAR-Agonist LY 518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic Syndrome
Objective—The study of PPARactivation on apoA-I production in humans has been limited to fibrates, relatively weak PPARagonists… 
2008
2008
Gateways to clinical trials.
(+)-Dapoxetine hydrochloride, (R)-Etodolac; Abatacept, ABT-510, Adalimumab, Agatolimod sodium, Alemtuzumab, Alvocidib… 
2007
2007
Abstract 681: Treatment With A Potent & Selective PPAR-{alpha} Agonist LY518674 Significantly Increases ApoA-I and ApoA-II Production Rates In Patients With Metabolic Syndrome Despite No Change In…
2007
2007
Use of CXCL10 levels to predict thyroid autoimmunity following IFN-α therapy
  • Nature Clinical Practice Endocrinology…
  • 2007
  • Corpus ID: 33280623
Fibrates are widely prescribed agonists of transcription factor peroxisome proliferatoractivated receptor (PPAR)-α, and are used… 
2007
2007
Highly potent PPAR-α agonist versus standard therapy in patients with lipid disorders
  • Nature Clinical Practice Endocrinology…
  • 2007
  • Corpus ID: 28477527
Fibrates are widely prescribed agonists of transcription factor peroxisome proliferatoractivated receptor (PPAR)-α, and are used… 
2007
2007
Gateways to clinical trials.
[111In]-DOTA-cG250, [131I]-Metuximab injection, [177Lu]-DOTA-cG250; Anatumomab mafenatox, AP-12009; BIBW-2992, Biricodar… 
2005
2005
propyl } phenoxy ) propanoic Acid ( LY 518674 ) , That Produces Marked Changes in Serum Lipids and Apolipoprotein A-1 Expression
Low high-density lipoprotein-cholesterol (HDL-c) is an important risk factor of coronary artery disease (CAD). Optimum therapy… 
2003
2003
Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonist.
A new series of hPPARalpha agonists containing a 2,4-dihydro-3H-1,2,4-triazol-3-one (triazolone) core is described leading to the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)